-
Traditional Chinese medicine sector: It is recommended to pay attention to Chinese medicine formula granules and brand OTC enterprises
Time of Update: 2022-10-20
Red Sun Pharmaceutical is expected to grow rapidly in volume and price in 2023 Hongri Pharmaceutical is a traditional Chinese medicine enterprise controlled by Tianjin State-owned Assets Supervision and Administration Commission, which currently has a layout of traditional Chinese medicine formula granules, finished drugs, medical devices, raw and auxiliary materials, medical and health services and intelligent supply chain of pharmaceutical devices.
-
More than 300 companies have received institutional attention, and 28 pharmaceutical and biological companies have been intensively investigated
Time of Update: 2022-10-20
com) In the pharmaceutical and biological industry, a total of 28 companies have been surveyed by more than 20 institutions, and the opening of medical treatment has attracted much attention, and as many as 227 institutions have participated in the research; Navitas, followed by Navitas, which was surveyed by 222 institutions; In addition, SMOC has also been investigated by 200 institutions, and the number of institutions has reached 206.
-
The pharmaceutical industry is emerging a wave of digitalization, and pharmaceutical companies will have great prospects
Time of Update: 2022-10-20
js?cdnversion='+~(-new Date()/36e5)]; In recent years, with the development of technologies such as intelligent IoT and big data, digitalization has gradually begun to become a competitive factor among pharmaceutical companies.
-
The first generic drug has exploded! Hengrui, Kelun... 57 first-class generic drugs were approved
Time of Update: 2022-10-20
The news of the approval of the first generic drug continues! Recently, Ke Lun, Shutai God, and Renfu have successively won the first imitation. Since the beginning of this year, 57 first-class gener
-
Heilongjiang Province regulates the guidance on the processing of traditional Chinese medicinal materials (cut while fresh).
Time of Update: 2022-10-20
Traditional Chinese medicine manufacturing enterprises shall carry out self-collection and self-production of self-collection and self-production, shall evaluate their quality assurance capabilities and risk management capabilities, and after self-inspection and meet the requirements of fresh cutting, they shall inform the provincial food and drug administration of the audit and evaluation report and the list of reports on the production area of Chinese herbal medicines (Annex 2), and list them in the annual drug report.
-
Since October, a number of pharmaceutical companies have been fined for selling inferior drugs
Time of Update: 2022-10-20
1 and Article 126 of the Drug Administration Law, and Article 75 of the Implementation Regulations of the Drug Administration Law, and the amount of the fine was not disclosed 。 On October 8 and 10, the Sichuan Provincial Food and Drug Administration announced an administrative penalty information, Sichuan Xinkang Traditional Chinese Medicine Pieces Co.
-
The third quarter performance forecast of medical device listed companies has been disclosed one after another, and the overall growth has been maintained
Time of Update: 2022-10-20
9 billion yuan in the first half of the year, a year-on-year increase of about 20%; The net profit attributable to shareholders of listed companies is expected to be about 2.
-
Multinational pharmaceutical companies are frequently selling assets to focus on their main business
Time of Update: 2022-10-20
Bayer's Environmental Science business unit offers products for the control of pests, diseases and weeds in non-agricultural areas.
Bayer's Environmental Science business unit offers products for the control of pests, diseases and weeds in non-agricultural areas.
-
Policy force + demand-driven, the pharmaceutical equipment industry is expected to usher in a critical period of development
Time of Update: 2022-10-20
Demand-driven Biomedicine is the pillar industry for the development of bioeconomy, in recent years, by the multiple resonance of policies, capital, talents and so on, China's biopharmaceutical industry has ushered in a period of vigorous development, new technologies in the field of biopharmaceuticals have emerged one after another, and the demand for the upstream supply chain market has increased significantly, bringing huge market space to biopharmaceutical equipment and consumables.
-
The continuous involution of the domestic innovative drug industry will accelerate the forced pharmaceutical companies to move towards real innovation
Time of Update: 2022-10-20
com) The involution of domestic innovative drugs will accelerate the forced pharmaceutical companies to real innovation (Image source: Pharma.
com) In this regard, industry insiders believe that this is the result of the serious homogenization of domestic innovative drug research and development and the tendency of competition to be involutional.
-
Wuling mushroom powder patent in hand, Zuoli Pharmaceutical market share leading!
Time of Update: 2022-10-20
traditional Chinese medicine Third, the rise and fall of the Spirit Lotus granules Table 2: Lotus granules rise and fall table (yuan/kg) From January 2021 to October 2022, the price of 5 raw material varieties increased, accounting for 71%, and the price of 2 raw materials decreased, accounting for 29%.
-
A number of pharmaceutical companies ran out of "acceleration" in the first three quarters! In the fourth quarter, the pharmaceutical sector is still optimistic about brokers
Time of Update: 2022-10-20
The market situation of the sector in the fourth quarter is still optimistic about brokerages In the long run, many securities firms, including Deppon Securities, Soochow Securities, and Kaiyuan Securities, still expressed their optimism about the market of the pharmaceutical sector in the fourth quarter, and suggested paying attention to the tracks of traditional Chinese medicine, consumer medical care, innovative drugs, and medical devices in the sub-sectors.
-
The 4 pharmaceutical companies expect the upper limit of the year-on-year increase in net profit in the first three quarters to exceed 100%!
Time of Update: 2022-10-20
The recent period is the forecast disclosure period for the first three quarters of listed companies. Flush data shows that as of October 14, nine companies in the A-share pharmaceutical and biologic
-
The country's first drug packaging reduction guide was released to reduce costs and increase efficiency in packaging
Time of Update: 2022-10-20
Before Shanghai issued the group standard for the reduction of pharmaceutical packaging, ten boxes were originally put into such a medium-sized packaging cartons.
Before Shanghai issued the group standard for the reduction of pharmaceutical packaging, ten boxes were originally put into such a medium-sized packaging cartons.
-
Hold the Zhongjing Health Festival to benefit the health of the public with Chinese medicine
Time of Update: 2022-10-20
After more than two years of promotion, Zhongjing's "Three Minutes to Explain the Classics" has received wide attention and recognition from the industry, won the 2021 China Pharmaceutical Top Ten Marketing Case Award, the 2022 West Lake Forum Innovative Marketing Case Award, was listed as a national cultural science popularization project by the Chinese Association of Traditional Chinese Medicine, and was officially announced to be launched nationwide during the Nanyang Medical Festival in October 2021.
-
The process of upgrading domestic pharmaceutical equipment has begun, and domestic substitution is coming
Time of Update: 2022-10-20
It is understood that in the first half of 2022, the performance of many listed companies of pharmaceutical equipment has been red, among which Chutian Technology and Dongfulong have achieved revenue growth of more than 20%, and net profits have increased significantly.
-
China's new coronavirus vaccine research and development has made these new progress
Time of Update: 2022-10-20
The reporter recently learned from the scientific research team of the joint prevention and control mechanism of the State Council and related scientific research teams that China adheres to multiple technical routes in parallel, and new progress has been made in the research and development of new coronavirus vaccines.
-
Medical devices are facing the tide of research, and these companies have attracted much attention
Time of Update: 2022-10-20
Data show that in the first three quarters of this year, a total of 2,242 A-share listed companies received institutions and made public research records, an increase of more than 400 over the same period last year.
-
Why insist? How to do it? Experts explained in detail the general policy of epidemic prevention and control
Time of Update: 2022-10-20
No country in the world is completely "lying flat" China still has to insist on "dynamic zero" As the global new crown pneumonia epidemic spreads into its third year, the prevention and control strategies of some countries have shifted from the previous prevention of infection to the focus on preventing severe disease, preventing death and preventing the crowding of medical resources, such as some countries relaxing or even canceling entry restrictions or domestic social restrictions.
-
Hubei Provincial Hospital of Integrated Traditional Chinese and Western Medicine Traditional Chinese Medicine Meridian Detector and Other Equipment Consultation Announcement
Time of Update: 2022-10-20
A batch of equipment procurement project of Hubei Province Hospital of Integrated Traditional Chinese and Western Medicine Potential suppliers of procurement projects should pick up and obtain procurement documents online/by mail, Room 2308, 23rd Floor, New Beacon International Hotel, No. 151 Xinhua Road, Jianghan District, Wuhan, and submit the response documents before 09:30 (Beijing time) on October 25, 2022.
